TLR4 and rheumatoid arthritis: Both stromal and immune cells express TLR4 in the RA joint; identification of biological processes and effector molecules that are modulated by FBG blockade in each of these different cell types during disease amelioration may reveal new opportunities for suppressing inflammation.